company background image
6499 logo

Medeon Biodesign TPEX:6499 Stock Report

Last Price

NT$41.00

Market Cap

NT$3.8b

7D

8.8%

1Y

-10.3%

Updated

07 Feb, 2025

Data

Company Financials

6499 Stock Overview

Researches, develops, manufactures and sells medical devices in Taiwan and the United States. More details

6499 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Medeon Biodesign, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medeon Biodesign
Historical stock prices
Current Share PriceNT$41.00
52 Week HighNT$54.90
52 Week LowNT$37.05
Beta0.72
1 Month Change4.33%
3 Month Change-10.87%
1 Year Change-10.28%
3 Year Change-39.22%
5 Year Change-4.01%
Change since IPO-57.77%

Recent News & Updates

Recent updates

Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Feb 09
Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Shareholder Returns

6499TW Medical EquipmentTW Market
7D8.8%6.5%-0.03%
1Y-10.3%-5.4%27.3%

Return vs Industry: 6499 underperformed the TW Medical Equipment industry which returned -5.5% over the past year.

Return vs Market: 6499 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 6499's price volatile compared to industry and market?
6499 volatility
6499 Average Weekly Movement3.3%
Medical Equipment Industry Average Movement3.9%
Market Average Movement4.5%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 6499 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6499's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/aYue-Teh Jangwww.medeonbiodesign.com

Medeon Biodesign, Inc. researches, develops, manufactures and sells medical devices in Taiwan and the United States. It engages in developing surgical equipment such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose, to prevent port site herniation caused by improper closure. In addition, the company is involved in manufacturing and sale of injection molding.

Medeon Biodesign, Inc. Fundamentals Summary

How do Medeon Biodesign's earnings and revenue compare to its market cap?
6499 fundamental statistics
Market capNT$3.78b
Earnings (TTM)-NT$801.29m
Revenue (TTM)NT$270.93m

13.9x

P/S Ratio

-4.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6499 income statement (TTM)
RevenueNT$270.93m
Cost of RevenueNT$198.09m
Gross ProfitNT$72.84m
Other ExpensesNT$874.13m
Earnings-NT$801.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-8.70
Gross Margin26.88%
Net Profit Margin-295.75%
Debt/Equity Ratio0%

How did 6499 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 06:27
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medeon Biodesign, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsiu Chi LinMasterlink Securities Corp.